...A, a small seed round and grants. Early this year, the company’s AI-guided approach to mAb discovery...

...Expression Technology, a bacteria-based protein expression platform. Ligand said the technology will complement its existing mAb discovery...

...screen on the order of a few hundred mAbs, noting that the targeted nature of mAb discovery...

...COVID-19, VIR-7831 and VIR-7832, are based on S309. Vir Biotechnology Inc. (NASDAQ:VIR) has approached COVID-19 mAb discovery...

...see “GSK Invests $250M in Vir” ). AstraZeneca plc (LSE:AZN; NYSE:AZN), too, has launched a mAb discovery...

...was released; design and manufacturing took 25 days. Neurimmune and Ethris Neurimmune is pairing its mAb discovery...

...development of COVID-19 mAbs. The deal gives WuXi Biologics commercialization rights in Greater China. Vir’s mAb discovery...

...Tuesday a collaboration to develop and manufacture mAbs to treat COVID-19. The partnership combines Vir’s mAb discovery...

...COVID-19’s ark At least five company and academic teams have disclosed use of specific mAb discovery...
...Antibodies Ltd. (TSX-V:IPA; Pink:IPATF), said Thursday it will combine its B Cell Select and DeepDisplay mAb discovery...

...diseases and viral vector technologies, told BioCentury last week that the company had started COVID-19 mAb discovery...